Vacationing from Osteoporosis Drug

Here's a little of an article that I found quite interesting.

TUESDAY, Dec. 26 (HealthDay News) -- In a nod to the adage that you can get enough of a good thing, a new study found that most postmenopausal women who stopped taking the osteoporosis drug Fosamax after five years did not increase their risk for nonvertebral fractures over the next five years.
But they did show a moderate drop in bone-mineral density.
"There are a subset of women who can probably stop for a certain period of time," said study lead author Dennis Black, professor of epidemiology and biostatistics at the University of California, San Francisco. "These tend to be women who are at a lower risk for fractures, maybe don't have previous fractures, and their bone density is not really low."
"On the other hand, women who are at very high risk, especially for fractures of the spine, might be better off continuing on the drug," Black said.